Skip to main content
Premium Trial:

Request an Annual Quote

Qiagen Reports 9-Percent Increase in Q4 Sales; Consumables Segment Jumps 11 Percent

NEW YORK, Feb. 14 (GenomeWeb News) - Qiagen yesterday reported a 9-percent increase in sales and a 6-percent rise in net profit for the fourth quarter.

 

Revenues for the three months ended Dec. 31, 2005, increased to $104.3 million from $95.5 million in the year-ago period.

 

Qiagen's net income for the fourth quarter rose to $16.9 million from $15.8 million in Q4 2004.

 

The company's consumables business, which contributed about 88 percent to net sales, grew approximately 11 percent in the fourth quarter compared with the same period one year ago.

 

R&D expenses for the fourth quarter rose to $10.7 million from $9.5 million in Q4 2004, Qiagen said.

 

As of Dec. 31, Qiagen had approximately $191.7 million in cash and cash equivalents on hand.

The Scan

Self-Reported Hearing Loss in Older Adults Begins Very Early in Life, Study Says

A JAMA Otolaryngology — Head & Neck Surgery study says polygenic risk scores associated with hearing loss in older adults is also associated with hearing decline in younger groups.

Genome-Wide Analysis Sheds Light on Genetics of ADHD

A genome-wide association study meta-analysis of attention-deficit hyperactivity disorder appearing in Nature Genetics links 76 genes to risk of having the disorder.

MicroRNA Cotargeting Linked to Lupus

A mouse-based study appearing in BMC Biology implicates two microRNAs with overlapping target sites in lupus.

Enzyme Involved in Lipid Metabolism Linked to Mutational Signatures

In Nature Genetics, a Wellcome Sanger Institute-led team found that APOBEC1 may contribute to the development of the SBS2 and SBS13 mutational signatures in the small intestine.